Ticagrelor is a platelet aggregation inhibitor. It is used for the prevention of thrombotic events (for example stroke or heart attack) in people with acute coronary syndrome or myocardial infarction with ST elevation.
This report contains market size and forecasts of Ticagrelor in global, including the following market information:
Global Ticagrelor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ticagrelor Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Ticagrelor companies in 2021 (%)
The global Ticagrelor market was valued at 1155.5 million in 2021 and is projected to reach US$ 1613 million by 2028, at a CAGR of 4.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
90 mg Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ticagrelor include Astrazeneca, Pfizer, Bayer, Johnson & Johnson, Merck, Boehringer Ingelheim, Eli Lilly and Sun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ticagrelor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ticagrelor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Ticagrelor Market Segment Percentages, by Type, 2021 (%)
90 mg Tablet
60 mg Tablet
Global Ticagrelor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Ticagrelor Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Ticagrelor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Ticagrelor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ticagrelor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ticagrelor revenues share in global market, 2021 (%)
Key companies Ticagrelor sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Ticagrelor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astrazeneca
Pfizer
Bayer
Johnson & Johnson
Merck
Boehringer Ingelheim
Eli Lilly
Sun Pharmaceutical